Prothrombin Complex Concentrate (Human) for injection
What is this medicine?
PROTHROMBIN COMPLEX CONCENTRATE (proh THROM bin KUM pleks KON suhn treyt) is used in patients who are taking a vitamin K antagonist like warfarin to stop bleeding or when urgent surgery is needed.
How should I use this medicine?
This medicine is for infusion into a vein. It is given by a health care professional in a hospital or clinic setting.
Talk to your pediatrician regarding the use of this medicine in children. Special care may be needed.
What side effects may I notice from receiving this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
changes in vision
confusion, trouble speaking or understanding
cough or other signs of infection
fever or chills
shortness of breath, chest pain, swelling in a leg
sudden numbness or weakness of the face, arm or leg
trouble walking, dizziness, loss of balance or coordination
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
What may interact with this medicine?
This medicine may interact with the following medications:
What if I miss a dose?
This does not apply.
Where should I keep my medicine?
This drug is given in a hospital or clinic and will not be stored at home.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:
heart disease or recent heart attack
history of disseminated intravascular coagulation
history of heparin-induced thrombocytopenia
history of stroke or transient ischemic attack
peripheral vascular disease
an unusual or allergic reaction to prothrombin complex concentrate, heparin, other medicines, foods, dyes, or preservatives
pregnant or trying to get pregnant
What should I watch for while using this medicine?
Your condition will be monitored carefully while you are receiving this medicine.
September 30, 2017